Constitutive activation of STAT3 is associated with the acquisition of an interleukin 6-independent phenotype by murine plasmacytomas and hybridomas.

作者: Rashmi Rawat , G. Jonah Rainey , Cynthia D. Thompson , Michelle R. Frazier-Jessen , Robert T. Brown

DOI: 10.1182/BLOOD.V96.10.3514

关键词: Autocrine signallingCytokineGlycoprotein 130PlasmacytomaGrowth factorBiologySTAT3Cancer researchPhosphorylationSignal transduction

摘要: Interleukin 6 (IL-6), the major growth factor for myeloma cells, signals through activation of signal transducers and activators transcription (STAT) proteins. An important step in malignant progression murine plasmacytomas is transition from dependence on IL-6 to a state independence. To elucidate mechanism whereby independence occurs, intracellular signaling events elicited by both IL-6–dependent –independent hybridomas were compared. It was found that STAT3, key molecule involved signaling, constitutively activated phosphorylated IL-6–independent cell lines compared cells. Further comparison upstream pathways revealed JAK-1 present anti-phosphotyrosine immunoprecipitates cells; gp130 subset plasmacytomas, whereas other showed no detectable phosphorylation absence exogenous IL-6. Secretion capable supporting cells observed one but not others, making an autocrine unlikely explanation These findings provide evidence constitutive either receptor-proximal or associated with concomitant gp130, can contribute process

参考文章(51)
V Gouilleux-Gruart, F Gouilleux, C Desaint, JF Claisse, JC Capiod, J Delobel, R Weber-Nordt, I Dusanter-Fourt, F Dreyfus, B Groner, L Prin, STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients Blood. ,vol. 87, pp. 1692- 1697 ,(1996) , 10.1182/BLOOD.V87.5.1692.1692
RM Weber-Nordt, C Egen, J Wehinger, W Ludwig, V Gouilleux-Gruart, R Mertelsmann, J Finke, Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood. ,vol. 88, pp. 809- 816 ,(1996) , 10.1182/BLOOD.V88.3.809.809
Diane F. Jelinek, Jennifer J. Westendorf, Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression. Journal of Immunology. ,vol. 157, pp. 3081- 3088 ,(1996)
R Jove, DJ Fujita, KL Nelson, A Hudnall, R Catlett, T Smithgall, SP Ethier, R Garcia, CL Yu, Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells Cell Growth & Differentiation. ,vol. 8, pp. 1267- 1276 ,(1997)
R L Schlossman, A Ogata, M Urashima, G Teoh, D Chauhan, K C Anderson, S P Treon, IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. Journal of Immunology. ,vol. 159, pp. 2212- 2221 ,(1997)
T Kishimoto, S Akira, M Narazaki, T Taga, Interleukin-6 family of cytokines and gp130. Blood. ,vol. 86, pp. 1243- 1254 ,(1995) , 10.1182/BLOOD.V86.4.1243.BLOODJOURNAL8641243
Shizuo Akira, Tetsuya Taga, Tadamitsu Kishimoto, Interleukin-6 in biology and medicine Advances in Immunology. ,vol. 54, pp. 1- 78 ,(1993) , 10.1016/S0065-2776(08)60532-5
S J Burakoff, C L Yu, R Jove, Constitutive activation of the Janus kinase-STAT pathway in T lymphoma overexpressing the Lck protein tyrosine kinase. Journal of Immunology. ,vol. 159, pp. 5206- 5210 ,(1997)
M P Cancro, R P Nordan, W Gerhard, J Van Snick, S Rudikoff, D M Hilbert, P A Scherle, T cell derived IL-6 is differentially required for antigen-specific antibody secretion by primary and secondary B cells. Journal of Immunology. ,vol. 143, pp. 4019- 4024 ,(1989)